Alpharma To Launch First Topical NSAID Patch Flector In January
This article was originally published in The Pink Sheet Daily
Executive Summary
Ramp up to the launch includes a nearly three-fold increase in Alpharma’s sales capacity.
You may also be interested in...
Alpharma Withdraws Embeda NDA
Resubmission is planned shortly; launch of the abuse-deterrent painkiller remains on track for first quarter 2009.
Alpharma Withdraws Embeda NDA
Resubmission is planned shortly; launch of the abuse-deterrent painkiller remains on track for first quarter 2009.
Alpharma Submits Embeda Abuse-Deterrent Morphine Capsule To FDA
Company files NDA slightly ahead of potential competitor Remoxy, in development by Pain Therapeutics.